Hotbed/Location
Filter News
Found 736,717 articles
-
Women Who Don’t Smoke Face Greater Obesity Risk, Study in British Medical Journal
6/29/2011
-
Children’s Hay Fever Relieved by Cellulose Powder Without Adverse Effects, Queen Silvia Children's Hospital Study Suggests
6/29/2011
-
Biotechs and the New Normal
6/29/2011
-
Researcher Sounded Alarm on Medtronic, Inc.'s Infuse Years Ago
6/29/2011
-
Roche Loses UK Appeal Over Long-term Tarceva Use
6/29/2011
-
Acetylon Pharmaceuticals Raises $27 Million to Push Lead HDAC Inhibitor into Phase I/II Cancer Trials
6/29/2011
-
R&D Spending in India is Projected to Mushroom, Boston Consulting Group Report
6/29/2011
-
Bristol-Myers Squibb Company, Pfizer Inc. Blood Thinner Tops Warfarin in Stroke Study, Wows Investors
6/29/2011
-
Chemical Produced in Pancreas Prevented and Reversed Diabetes in Mice, St. Michael's Hospital Study
6/29/2011
-
University of Washington Department of Genome Sciences Joins Illumina, Inc. Genome Network
6/29/2011
-
Pfizer Inc. Lung Cancer Pill May Double Survival
6/29/2011
-
Walvax Will Spend $112 Million to Up Vaccine Capacity
6/29/2011
-
Wuhan Kindstar Diagnostics Raises $11 Million in Series B Funding
6/29/2011
-
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare Release: EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration
6/29/2011
-
Immune Response BioPharma Sends Open Letter To FDA Seeks Emergency NDA Approval Of Remune HIV/AIDS Vaccine
6/29/2011
-
Amsterdam Molecular Therapeutics (AMT)' Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients
6/29/2011
-
QRxPharma Pty Ltd. Releases Additional Data on Phase 3 Comparative Safety Study for MoxDuo® IR
6/29/2011
-
Additional Data on Provectus Pharmaceuticals Inc.’s PV-10 for Metastatic Melanoma Presented at Prominent Melanoma Conferences
6/29/2011
-
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
6/29/2011
-
FDA Clears Mesoblast Limited Phase 2 Trial to Treat Degenerative Disc Disease
6/29/2011